Biomedical Research

Journal Banner

Clinical application of platelet-rich plasma for the treatment of refractory sinus wounds

Junjie Xia#, Zhiming Ni# and Hong Ye*

Department of Orthopaedic, 117th Hospital of PLA, Hangzhou, Zhejiang, PR China

#These two authors contributed equally to this paper

*Corresponding Author:
Hong Ye
Department of Orthopaedic
117th Hospital of PLA
PR China

Accepted date: July 18, 2017

Visit for more related articles at Biomedical Research

Abstract

Objective: To evaluate the clinical efficacy of Platelet-Rich Plasma (PRP) in the treatment of refractory sinus wounds.

Methods: Twelve patients with refractory sinus wounds were recruited for this study. Among them, the sinus wounds in eight patients were caused by fracture fixation and in four patients were caused by trauma. The PRP was locally injected following wound debridement. The strength of pain and wound healing were observed after treatment.

Results: In the 12 cases that were treated with PRP, 7 cases exhibited significant pain relief, 6 cases were partly healed and 6 cases were completed healed.

Conclusions: The local injection of PRP which is simple and safe has shown significant healing efficiency and pain relief in the treatment of refractory sinus wounds.

Keywords

Platelet-rich plasma, Sinus wound, Wound healing

Introduction

In the treatment of orthopaedic trauma, the Vacuum-Sealing- Drainage (VSD) technique is widely recognized for repairing soft tissues with favourable therapeutic efficiency, however, it has obvious limitations in the treatment of chronic sinus wounds. Traditional therapy combines antibiotics with dressing changes for the treatment of sinus wounds, however, often leads to long course and poor wound healing. In the current study, we try to repair the sinus wound through local injection of PRP and the particulars are as follows.

Methods

General information

The study includes 12 cases, 7 cases are male and 5 cases are female with an average age of 54 (37~68 y old). In addition, the sinuses in 8 cases were caused by wound infection after fracture fixation with an average treatment course of 5 months (3~10 months), and the sinuses in the other 4 cases were caused by trauma-mediated soft tissue contusion with an average treatment course of 3 months (2~6 months). During treatment, 12 patients received X-ray examination and no osteomyelitis was found. Before PRP injection, the patients were treated by antibiotics and dressing changes and all of them had different degrees of pain. According to the Faces Rating Scale-Revised (FRS-R) scores [1], 3 cases had mild pain, 7 cases had moderate pain, and 2 cases had severe pain as shown in Table 1.

Patient number Age (year) Gender Wound position Wound size (length × width × depth cm3) Treatment course (month) Pain level
1 37 male The middle-lower inside of left crus 3 × 2 × 4 2 severe
2 42 male The lower front side of Left crus 3 × 1.5 × 1 3 moderate
3 43 female The distal inside of right crus 1 × 1 × 4 1 moderate
4 48 male The middle-lower anterolateral side of left crus 2.5 × 2 × 1 5 mild
5 48 male The posterolateral side of left forearm  2 × 1.6 × 4 6 moderate
6 50 female The middle-lower lateral side of left crus 1.5 × 1 × 2.8 5 mild
7 52 male The left inner ankle 1.8 × 1.3 × 2.5 3 moderate
8 60 male The middle-upper lateral side of right crus 3 × 2 × 4 3 moderate
9 65 female The distal anterolateral side of left crus 3 × 1.7 × 1.5 10 mild
10 67 female The middle-lower inside of left crus 4 × 3.5 × 5.5 6 severe
11 68 male The middle anterolateral side of left crus 4 × 3 × 2 4 moderate
12 68 female The right external ankle 2 × 1 × 1.2 4 moderate

Table 1: Patient’s general information

Treatment and observation

The preparation and usage of PRP: The centrifugation was performed on WG-FZLXJ-I centrifuge and PRP was prepared by commercial kit under aseptic operation. Firstly, 45 mL blood was withdraw from patient’s peripheral venous by using the 50 mL syringes which contained 5 mL sodium citrate solution for anticoagulation, shaked properly and injected into the centrifuge tube.

Centrifuged the samples according to the Landesberg method [2] for 10 min at 200 g and the whole blood was divided into three layers, the top layer is the supernatant, the under layer is the erythrocyte, and the middle layer in light yellow is the PRP layer. The erythrocyte layer was removed by syringe with 3-5 mm left in the tube. The remaining sample was mixed well and centrifuged again for 10 min at 200 g. 3/4 supernatant was discarded and the PRP was extracted by syringe.

Normally, 5 mL PRP can be produced each time. The wound was injected with PRP until the sinus was filled up, and covered with sterile transparent membrane. After 7 to 10 d, the membrane was removed and the operation can be repeated again if necessary. The 12 patients in this study were treated with antibiotics and the wounds were debrided with no obvious purulent secretion before using PRP.

Observation

The pain degree was determined by the FRS-R scores and the wound healing was monitored after the PRP treatment.

Results

Pain grading

There are 9 patients with moderate or severe pain. After the PRP treatment, 7 patients showed significant pain relief in 1-2 d, and 5 patients had no obvious pain relief.

Wound healing

The following are the criteria of wound healing. Cured: the wound is healed and covered by epithelial tissue; Effective: the wound has no secretion with shrinking ulcer surface, the granulation tissue grows well, and the epithelial tissue begins to cover the wound; Invalid: there is no granulation tissue growth or shrinkage in the wound. Among the 12 patients under PRP treatment in this study, 6 patients were cured and the other 6 patients also showed effective responses. The pain grades and wound healing of patients are summarized in Table 2. Figures 1-6 show the treatment process and wound healing of the third patient.

Patient number Treatment time (month) The number of PRP operations Pain grade Wound healing
1 2 2 mild cure
2 3 2 mild cure
3 1 1 moderate cure
4 5 1 mild cure
5 6 3 moderate effective
6 5 2 mild cure
7 3 3 mild effective
8 3 4 mild effective
9 10 2 mild cure
10 6 4 moderate effective
11 4 3 mild effective
12 4 2 mild effective

Table 2: Pain grade and wound healing after the PRP treatment.

biomedres-peripheral-venous

Figure 1: 50 ml blood extracted from peripheral venous blood.

biomedres-Blood-stratification

Figure 2: Blood stratification after the first centrifugation.

biomedres-Sinus-wound

Figure 3: Sinus wound of the third patient.

biomedres-Inject-PRP

Figure 4: Inject the PRP into the wound through the sinus.

biomedres-sterile-transparent

Figure 5: Cover the wound with sterile transparent membrane.

biomedres-Wound-healing

Figure 6: Wound healing.

Discussion

Wound healing is a complex process which depends on the coordination of cytothesis, inflammatory cells, extracellular matrix and growth factors to rebuild the damaged soft tissue [3].

There are three main results of wound healing: healed, scar healing, chronic ulcer. During the whole process of tissue healing, the growth factors from platelet play an important role [4,5]. PRP is produced through blood centrifugation which is a mixture and contains rich platelet and growth factors.

The growth factors include Platelet-Derived Growth Factor (PDGF), transforming growth factor (TGF-ß), Fibroblast Growth Factor (FGF), Vascular Endothelial Growth Factor (VEGF), Insulin-like Growth Factor 1 (IGF 1) and Epidermal Growth Factor (EGF) [6].

Local application of these growth factors can activate the inactive macrophages which can release the cytokines such as TGF, EGF in the wound and speed the process of wound healing [7].

The PRP contains a large amount of fibrin which acts a good support for wound healing and stimulates soft tissue regeneration; VEGF is able to stimulate angiogenesis and enhance early wound healing; EGF can accelerate the skin growth, relieve local wound swelling and pain, and reduce postoperative wound exudation.

The PRP demonstrates excellent repairing effects in both acute and chronic refractory wounds. In recent years, PRP technology has been widely used in the treatment of refractory wounds [8,9], soft tissue injury and bone non-union [10-12].

Studies have shown that the injection of PRP into knee joint could improve the restoration of knee joint cartilage and achieved favourable therapeutic effects in the treatment of senile gonarthritis [13,14].

All of the 12 clinical cases in this study are refractory sinus wounds. Among them, 7 cases with moderate or severe pain showed significant pain relief after PRP treatment. The remaining 5 cases had mild pain before PRP treatment and thus lack comparison. These results suggest that PRP is able to significantly relieve pain in wound healing. Carter et al. [15] have reported that PRP contains a large number of white cells and mononuclear cells which can suppress the local inflammation of wounds and ease the pain. Zhang et al. [16] also reported similar results. In our current study, the efficiency of wound healing by the application of PRP is 100%. Several similar results have also been reported [8,17-19] which further confirm the significant therapeutic efficiency of PRP.

The PRP is produced through the centrifugation of blood from patients. Therefore, PRP is very safe with high histocompatibility. In addition, the preparation of PRP is simple. However, the most important thing is, compared with the VSD therapy for the treatment of sinus wounds, the liquid PRP can be directly injected into the sinus and contact the sinus surface adequately regardless of the wound depth which makes full use of the contained cytokines. Generally, the PRP exhibits notable therapeutic effects for the treatment of refractory sinus wounds which provides a novel and effective way for similar wound healing in clinical treatment.

References